ELI LILLY & Co is 187.0x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $5.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | LLY |
|---|---|---|
| Market cap | $5.73 B | $1.072 T |
| US-listed rank | #1294 | #10 |
| Revenue (latest FY) | $521.31M | $65.18B |
| Net income (latest FY) | -$23.36M | $20.64B |
| Net margin | -4.5% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 612 | 989 |
ELI LILLY & Co is 187.0x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $5.73 B).
In their latest fiscal years, Mirum Pharmaceuticals, Inc. reported $521.31M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Mirum Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.